Thus, not all PIK3CA-mutated breast cancer models might benefit from AKT blockers, as some may promote cell growth through an AKT-independent axis, such as PDK1/SGK3/mTORC1 [73,78]. This evidence concerns the gene AKT1 and breast carcinoma.